High compared with standard dose lipase pancreatic supplement.
Cotazym-S-Forte, a new pancreatic supplement containing 10,000 BP units of lipase activity per capsule, was compared with a standard dose pancreatin supplement (Pancrease) with 5000 BP units lipase activity in a randomised crossover trial. The number of capsules of Cotazym-S-Forte administered was half the usual number of Pancrease capsules and was associated with the same degree of fat absorption as Pancrease.
Robinson
P J
PJ
Professorial Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.
Olinsky
A
A
Smith
A L
AL
Chitravanshi
S B
SB
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000378:metabolism; D003692:Delayed-Action Preparations; D004041:Dietary Fats / Q000378:metabolism; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D008049:Lipase / Q000008:administration & dosage*; D008297:Male; D011897:Random Allocation
D003692:Delayed-Action Preparations; D004041:Dietary Fats; D008049:Lipase